Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Vasc Health Risk Manag ; 19: 317-323, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37215282

RESUMO

Resistant hypertension (RH) is characterized by being difficult to control, even with the use of various antihypertensive drugs and is associated with target organ lesions and other comorbidities. Thus, new treatment alternatives such as transcutaneous electrical nerve stimulation (TENS) can offer benefits to resistant hypertensive patients by reducing blood pressure (BP) in a non-invasive way and without the need for the association of more antihypertensive drugs. In this case, a patient with RH was submitted to three weekly applications of TENS on the stellate ganglion lasting 40 min each for 1 month. Peripheral and central hemodynamic assessments were performed by 24-h ambulatory BP monitoring (ABPM) before and after TENS applications. After completion of the TENS applications, significant reductions in office systolic (SBP) and diastolic BP (DBP) were observed. There was also a decrease in peripheral SBP and DBP in the 24-h ABPM and sleep and SBP during wakefulness. Additionally, central parameters including central SBP and pulse wave velocity presented a significant reduction in the 24-h ABPM, during the wakefulness and sleep. TENS is able to attenuate the sympathetic hyperactivity present in RH cases and decrease the peripheral and central hemodynamic parameters of a resistant hypertensive patient.


Assuntos
Hipertensão , Estimulação Elétrica Nervosa Transcutânea , Humanos , Anti-Hipertensivos/uso terapêutico , Análise de Onda de Pulso , Hipertensão/diagnóstico , Hipertensão/terapia , Hipertensão/complicações , Pressão Sanguínea/fisiologia , Monitorização Ambulatorial da Pressão Arterial
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA